BioCentury
ARTICLE | Company News

Alexion sales and marketing update

September 2, 2013 7:00 AM UTC

Alexion recalled a single lot of Orphan drug Soliris eculizumab due to the presence of visible particles in a limited number of vials distributed outside of the U.S. The company estimates the recalle...